NCT00763360

To Compare the Ability of DiscoVisc® OVD to Protect the Corneal Endothelium and Maintain Anterior Chamber Space With Healon® and Amvisc® PLUS During Cataract Surgery.

To Compare the Ability of DiscoVisc® Ophthalmic Viscosurgical Device (OVD) to Protect the Corneal Endothelium and Maintain Anterior Chamber Space With Healon® and Amvisc® PLUS During Cataract Surgery.

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 184 (actual)
• Sponsor: Alcon Research · Industry
• Sex: All
• Age: 49 Years
• Healthy volunteers: Not accepted

Summary

The objective of the study is to assess how DisCoVisc Ophthalmic Viscosurgical Device (OVD) compares with Healon and Amvisc Plus in the protection of corneal endothelial cells, and the ability to maintain anterior chamber space, in routine cataract surgery.

Conditions

• Cataract

Interventions

Type	Name	Description
DEVICE	DisCoVisc®	Injection of DisCoVisc® Ophthalmic Viscosurgical Device (OVD) into the anterior chamber prior to and throughout the cataract surgery procedure
DRUG	Healon	Injection of Healon into the anterior chamber prior to and throughout the cataract surgery procedure
DRUG	Amvisc Plus	Injection of Amvisc Plus into the anterior chamber prior to and throughout the cataract surgery procedure

Timeline

• Start date: 2008-05-01
• Primary completion: 2010-09-01
• First posted: 2008-09-30
• Last updated: 2012-01-24
• Results posted: 2012-01-24

Locations

1 site across 1 country: United States